Nanexa AB (publ) (NANEXA.ST) Stock Price & Growth Analysis

Quote Panel

Updated July 14, 2025

1W -13.58 % 1M -10.04 % 3M 59.06 % 1Y 143.89 %

Key Metrics

Market Cap
343.63M
Shares Outstanding
156.91M
Share in Float
112.60M
Dividende
0

Earning Date
27 Aug 2025
Price Target
2.19
Average Volume
901241
Beta
1.871

Range
0.701-3.15
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.nanexa.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

17.03x

P/S Ratio

3.52x

P/B Ratio

0.2

Debt/Equity

-159.4%

Net Margin

$-0.2

EPS

How NANEXA.ST compares to sector?

P/E Ratio

Fundamentals

Relative Strength

NANEXA.ST

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$112M

3800%

2026-Revenue

$102M

-1893%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.35
vs -0.31

Q1.23

N/A

-0.14
vs -0.24

Q2.23

N/A

-0.16
vs -0.31

Q3.23

N/A

-0.11
vs -0.23

Q4.23

N/A

-0.52
vs -0.35

Q1.24

N/A

-0.02
vs -0.14

Q2.24

N/A

-0.04
vs -0.16

Q3.24

N/A

-0.03
vs -0.11

Q4.24

N/A

-0.09
vs -0.52

Q1.25

N/A

-0.06
vs -0.02

Sales Growth

YoY

Current

Estimates

Q4.22

+22%

820K vs 670K

Q1.23

+2643%

8.2M vs 298K

Q2.23

+3528%

7.7M vs 211K

Q3.23

+337%

6.7M vs 1.5M

Q4.23

+731%

6.8M vs 820K

Q1.24

-5%

7.8M vs 8.2M

Q2.24

-26%

5.7M vs 7.7M

Q3.24

-4%

6.4M vs 6.7M

Q4.24

-34%

4.5M vs 6.8M

Q1.25

-63%

2.9M vs 7.8M

Return on Equity

QoQ

Q2.23

-11%

-0.11
vs -0.09

Q3.23

-8%

-0.08
vs -0.11

Q4.23

-53%

-0.53
vs -0.08

Q1.24

-3%

-0.03
vs -0.53

Q2.24

-7%

-0.07
vs -0.03

Q3.24

-5%

-0.05
vs -0.07

Q4.24

-16%

-0.16
vs -0.05

Q1.25

-10%

-0.10
vs -0.16

Institutionnal Ownership

Company Description

2.19SEK

N/A

17.03x

3.52x

0.2

-159.4%

$-0.2

$112M

$102M

Earnings Growth

Latest News

Company Description

2.19SEK

N/A

17.03x

3.52x

0.2

-159.4%

$-0.2